We found that SESN2 knockdown significantly slowed tumour growth in response to chemotherapeutic agents (Figure 6A); the tumour volume and weight are significantly decreased in the SESN2 shRNA + Cis group compared with those in the control shRNA + Cis group (Figures 6B,C). Here, SESN2 is linked to neoplasm.